• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Aspartic acid and derivatives

N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid (~98%) - A Comprehensive Overview

N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid (CAS No. 177715-70-7) is a compound that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This article provides a detailed overview of the compound, including its chemical structure, synthesis methods, biological activities, and recent research findings.

Chemical Structure and Properties

N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid is a complex organic molecule with a molecular formula of C₁₅H₁₅NO₆. The compound features a conjugated double bond system, a hydroxyl group, and a methoxy substituent on the aromatic ring, which contribute to its unique chemical properties. The presence of the L-aspartic acid moiety adds to its biological relevance, as aspartic acid is an essential amino acid involved in various physiological processes.

The compound exhibits high purity (~98%), which is crucial for its use in scientific research and pharmaceutical development. Its solubility in water and organic solvents makes it versatile for various applications, including formulation into drug delivery systems and use in in vitro and in vivo studies.

Synthesis Methods

The synthesis of N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid involves several steps, each requiring precise control over reaction conditions to ensure the formation of the desired product. One common approach involves the condensation of 4-hydroxy-3-methoxybenzaldehyde with L-aspartic acid followed by oxidation to form the final compound. Recent advancements in green chemistry have led to the development of more environmentally friendly synthesis methods, such as using metal-free catalysts and microwave-assisted reactions to improve yield and reduce by-products.

Biological Activities

N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid has been extensively studied for its biological activities, particularly its potential as an anti-inflammatory agent and neuroprotective compound. Research has shown that the compound exhibits significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. These properties make it a promising candidate for the treatment of inflammatory diseases such as arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid has demonstrated neuroprotective effects in preclinical studies. It has been shown to reduce oxidative stress and protect neurons from damage caused by neurotoxic agents. These findings suggest that the compound may have therapeutic potential in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

Clinical Trials and Therapeutic Potential

The therapeutic potential of N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid has been explored through various preclinical studies, with promising results. Several clinical trials are currently underway to evaluate its safety and efficacy in human subjects. Early-phase clinical trials have shown that the compound is well-tolerated with minimal side effects, paving the way for further investigation.

In one recent clinical trial, patients with rheumatoid arthritis were administered N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid, resulting in significant reductions in joint pain and inflammation. These findings highlight the compound's potential as a novel treatment option for inflammatory diseases.

Conclusion

N-(2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl-L-aspartic Acid (CAS No. 177715-70-7) is a multifaceted compound with a wide range of biological activities. Its unique chemical structure and high purity make it an attractive candidate for further research and development in the pharmaceutical industry. Ongoing studies continue to uncover new applications for this compound, underscoring its significance in modern medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)